We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

German Spondyloarthritis Inception Cohort (GESPIC)

This study is currently recruiting participants.
Verified March 2017 by Denis Poddubnyy, Charite University, Berlin, Germany
Sponsor:
ClinicalTrials.gov Identifier:
NCT01277419
First Posted: January 17, 2011
Last Update Posted: March 14, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
German Federal Ministry of Education and Research (BMBF): 2000-2007 and 2010-current
2010-current: AbbVie (Abbott)
Amgen
Centocor, Inc.
Schering-Plough
Wyeth is now a wholly owned subsidiary of Pfizer
2015-current: Berlin Institute of Health (BIH)
Information provided by (Responsible Party):
Denis Poddubnyy, Charite University, Berlin, Germany
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2020
  Estimated Primary Completion Date: July 2020 (Final data collection date for primary outcome measure)
Publications: